Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]    
Net revenue $ 16,842,000 $ 9,317,000
Cost of sales 14,656,000 8,768,000
Gross profit 2,186,000 549,000
Operating expenses:    
Selling and administrative expenses 9,761,000 7,712,000
Research and development 4,973,000 4,088,000
Total operating expenses 14,734,000 11,800,000
Operating loss (12,548,000) (11,251,000)
Other income 84,000
Interest expense (1,788,000) (1,247,000)
Net loss $ (14,336,000) $ (12,414,000)
Net loss per share - basic and diluted $ (2.80) $ (2.84)
Weighted average number of common shares outstanding - basic and diluted 5,118,713 4,364,271